President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk's Wegovy and Eli ...

Although Medicare by law is not allowed to cover drugs for ... the fiscal impacts of this proposal,” the National Association of Medicaid Directors said in a letter to CMS in late January.